[go: up one dir, main page]

WO2002019996A3 - Prevention of acute sinusitis and sinus attack - Google Patents

Prevention of acute sinusitis and sinus attack Download PDF

Info

Publication number
WO2002019996A3
WO2002019996A3 PCT/IB2001/001522 IB0101522W WO0219996A3 WO 2002019996 A3 WO2002019996 A3 WO 2002019996A3 IB 0101522 W IB0101522 W IB 0101522W WO 0219996 A3 WO0219996 A3 WO 0219996A3
Authority
WO
WIPO (PCT)
Prior art keywords
prevention
acute sinusitis
sinus
attack
sinus attack
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2001/001522
Other languages
French (fr)
Other versions
WO2002019996A2 (en
Inventor
James T Angello
Howard M Druce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Priority to MXPA03001437A priority Critical patent/MXPA03001437A/en
Priority to CA002419653A priority patent/CA2419653A1/en
Priority to AU2001279999A priority patent/AU2001279999A1/en
Priority to EP01958276A priority patent/EP1317259A2/en
Priority to BR0113747-6A priority patent/BR0113747A/en
Priority to JP2002524481A priority patent/JP2004508324A/en
Publication of WO2002019996A2 publication Critical patent/WO2002019996A2/en
Publication of WO2002019996A3 publication Critical patent/WO2002019996A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Adregnergic alpha agonists such as pseudoephedrine can be used to prevent sinusitus or sinus attack.
PCT/IB2001/001522 2000-09-08 2001-08-23 Prevention of acute sinusitis and sinus attack Ceased WO2002019996A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
MXPA03001437A MXPA03001437A (en) 2000-09-08 2001-08-23 Prevention of acute sinusitis and sinus attack.
CA002419653A CA2419653A1 (en) 2000-09-08 2001-08-23 Prevention of acute sinusitis and sinus attack
AU2001279999A AU2001279999A1 (en) 2000-09-08 2001-08-23 Prevention of acute sinusitis and sinus attack
EP01958276A EP1317259A2 (en) 2000-09-08 2001-08-23 Prevention of acute sinusitis and sinus attack
BR0113747-6A BR0113747A (en) 2000-09-08 2001-08-23 Prevention of Acute Sinusitis and Sinus Attack
JP2002524481A JP2004508324A (en) 2000-09-08 2001-08-23 Prevent acute sinusitis and sinus attacks

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65792900A 2000-09-08 2000-09-08
US09/657,929 2000-09-08

Publications (2)

Publication Number Publication Date
WO2002019996A2 WO2002019996A2 (en) 2002-03-14
WO2002019996A3 true WO2002019996A3 (en) 2002-06-13

Family

ID=24639223

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/001522 Ceased WO2002019996A2 (en) 2000-09-08 2001-08-23 Prevention of acute sinusitis and sinus attack

Country Status (7)

Country Link
EP (1) EP1317259A2 (en)
JP (1) JP2004508324A (en)
AU (1) AU2001279999A1 (en)
BR (1) BR0113747A (en)
CA (1) CA2419653A1 (en)
MX (1) MXPA03001437A (en)
WO (1) WO2002019996A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160324890A1 (en) * 2015-05-06 2016-11-10 Robert E. Weinstein Method and Device for Preventing Microbial Resistance

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0279976A1 (en) * 1987-01-28 1988-08-31 Alza Corporation Pseudoephedrine dosage form
WO1992017171A1 (en) * 1991-04-01 1992-10-15 Merck & Co., Inc. Ibuprofen-decongestant combinations
US5541210A (en) * 1993-12-17 1996-07-30 The Procter & Gamble Company 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 andrenoceptor agonists
WO1998023612A1 (en) * 1996-11-25 1998-06-04 The Procter & Gamble Company 2-imidazolinylaminobenzothiazole compounds useful as alpha-2 adrenoceptor agonists
WO1998023596A1 (en) * 1996-11-25 1998-06-04 The Procter & Gamble Company Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
WO1999015173A1 (en) * 1997-09-19 1999-04-01 The Procter & Gamble Company Compositions and methods for treating respiratory disorders
US5948414A (en) * 1998-03-24 1999-09-07 Nouveau Technologies, Inc. Herbal based nasal spray

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0279976A1 (en) * 1987-01-28 1988-08-31 Alza Corporation Pseudoephedrine dosage form
WO1992017171A1 (en) * 1991-04-01 1992-10-15 Merck & Co., Inc. Ibuprofen-decongestant combinations
US5541210A (en) * 1993-12-17 1996-07-30 The Procter & Gamble Company 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 andrenoceptor agonists
WO1998023612A1 (en) * 1996-11-25 1998-06-04 The Procter & Gamble Company 2-imidazolinylaminobenzothiazole compounds useful as alpha-2 adrenoceptor agonists
WO1998023596A1 (en) * 1996-11-25 1998-06-04 The Procter & Gamble Company Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
WO1999015173A1 (en) * 1997-09-19 1999-04-01 The Procter & Gamble Company Compositions and methods for treating respiratory disorders
US5948414A (en) * 1998-03-24 1999-09-07 Nouveau Technologies, Inc. Herbal based nasal spray

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FIREMAN P.: "Treatment strategies designed to minimize medical complications of allergic rhinitis.", AMERICAN JOURNAL OF RHINOLOGY, (1997) 11/2 (95-102)., XP002127890 *
MELEN I ET AL: "Effects of Phenylpropanolamine on Ostial and Nasal Patency in Patients Treated for Chronic Maxillary Sinusitis.", ACTA OTOLARYNGOL. (101, NO. 5-6, 494-500, 1986) 2 FIG. 3 TAB. 14 REF. CODEN: AOLAAJ ISSN: 0001-6489, Leo, XP008002013 *

Also Published As

Publication number Publication date
BR0113747A (en) 2003-06-24
JP2004508324A (en) 2004-03-18
MXPA03001437A (en) 2005-06-03
EP1317259A2 (en) 2003-06-11
WO2002019996A2 (en) 2002-03-14
AU2001279999A1 (en) 2002-03-22
CA2419653A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2524902A (en) Use of MoO<sub>3</sub> as corrosion inhibitor, and coating composition containing such an inhibitor
AU2001277025A1 (en) Universal transaction manager agent, systems and methods
ZA979238B (en) The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors.
AU2002366236A1 (en) Advertising and content management systems and methods
EP1290149A4 (en) Thermostable reverse transcriptases and uses thereof
AU2001247782A1 (en) 18221, dual specificity phosphatase and uses thereof
ZA979236B (en) The preparation and use of ß-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors.
AU2001297724A1 (en) Electronic game enhancement systems and methods
MXPA03000694A (en) New use of lipase inhibitors.
AU2001242970A1 (en) Information-related devices and methods
ITMI20000003A0 (en) PROCESS FOR THE PREPARATION OF PERFLUOROPOLIS OR CHILENES WITH hydroxyl terminals
WO2001068146A3 (en) Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2001285914A1 (en) Improved swellable phyllosilicates
AU2001232809A1 (en) Gyrase inhibitors and uses thereof
WO2002019996A3 (en) Prevention of acute sinusitis and sinus attack
AU2001255696A1 (en) Telomerase inhibitors and methods of their use
AU2002239438A1 (en) 2,4-hexadienoic acid and derivatives as corrosion inhibitors
AU2001288357A1 (en) Methods of preventing or treating west nile virus and other infections
WO2001053352A3 (en) Sperm specific proteins
AU2001252627A1 (en) Polybenzasol fiber and use of the same
PL360310A1 (en) Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
EP1166789A3 (en) Arsenolite containing angiogenesis inhibitor
AU5571799A (en) Angiogenesis inhibitors and uses thereof
AU2001293557A1 (en) New inhibitors of iapp fibril formation and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/001437

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2419653

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001958276

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2002524481

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2001958276

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001958276

Country of ref document: EP